Comorbid Attention Deficit/Hyperactivity Disorder and Substance Use Disorder: Treatment Considerations

Publisher： Bentham Science Publishers

E-ISSN： 1874-4745|5|3|190-198

ISSN： 1874-4737

Source： Current Drug Abuse Reviews, Vol.5, Iss.3, 2012-09, pp. : 190-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Attention-Deficit/Hyperactivity Disorder Subtypes in Adolescents with Comorbid Substance-Use Disorder

By Tamm Leanne   Adinoff Bryon   Nakonezny Paul A.   Winhusen Theresa   Riggs Paula  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 1, 2012-01 ,pp. : 93-100

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Attention Deficit Hyperactivity Disorder Comorbid with Epilepsy

By  

Child and Adolescent Psychopharmacology News, Vol. 16, Iss. 2, 2011-04 ,pp. : 5-8

Guilford Publications Inc

Access to resources Recommend Favorite

Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

By Dell'Agnello Grazia  

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 739-753

Adis International

Access to resources Recommend Favorite

Parental warmth and risks of substance use in children with attention-deficit/hyperactivity disorder

By Tandon Mini   Tillman Rebecca   Spitznagel Edward   Luby Joan  

Addiction Research and Theory, Vol. 22, Iss. 3, 2014-06 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite

Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders

By  

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3359-3366

Bentham Science Publishers

Access to resources Recommend Favorite